|
Volumn 18, Issue 6, 2001, Pages 212-216
|
Primary care prevention of cardiovascular disease in diabetes
|
Author keywords
Clinical governance; Diabetes mellitus; Primary and secondary prevention of cardiovascular disease; Risk factors
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMFEBUTAMONE;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NICOTINE;
PRAVASTATIN;
SIMVASTATIN;
STATIN;
ADDICTION;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
DIABETES MELLITUS;
DOSE RESPONSE;
DRUG COST;
EVIDENCE BASED MEDICINE;
FAMILY HISTORY;
GENERAL PRACTITIONER;
GOOD CLINICAL PRACTICE;
HEALTH CARE COST;
HEALTH CARE MANAGEMENT;
HEALTH CARE PLANNING;
HEALTH CARE SYSTEM;
HIGH RISK PATIENT;
HYPERLIPIDEMIA;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
MEDICAL AUDIT;
MEDICAL PRACTICE;
NATIONAL HEALTH SERVICE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PATIENT CARE;
PRIMARY HEALTH CARE;
PRIMARY PREVENTION;
PROTEINURIA;
RESOURCE MANAGEMENT;
REVIEW;
RISK FACTOR;
SECONDARY PREVENTION;
SLOW DRUG RELEASE;
SMOKING;
UNITED KINGDOM;
|
EID: 0034867332
PISSN: 13578170
EISSN: None
Source Type: Journal
DOI: 10.1002/pdi.226 Document Type: Review |
Times cited : (2)
|
References (21)
|